Clinical Trial Update: EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer [NA]

View source ↗

Summary

This clinical trial update reports completion of a study using EF5 to image tumor hypoxia in women with stage IIB, stage IIIB, or stage IVA cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• EF5

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | NA | Status: COMPLETED